Proceedings of the National Academy of SciencesMicrobiologyPeer-reviewed journal article
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
S. Ding, R. Zang, J. B. Case, M. F. Gomez Castro, Z. Liu, Q. Zeng, H. Zhao, J. Son, P. W. Rothlauf, G. Hou, S. Bose, X. Wang, M. D. Vahey, T. Kirchhausen, D. H. Fremont, M. S. Diamond, S. P. J. Whelan
Abstract
Cholesterol 25-hydroxylase (CH25H) is an interferon-stimulated gene (ISG) that shows broad antiviral activities against a wide range of enveloped viruses. Here, using an ISG screen against VSV-SARS-CoV and VSV-SARS-CoV-2 chimeric viruses, we identified CH25H and its enzymatic product 25-hydroxycholesterol (25HC) as potent inhibitors of virus replication. Mechanistically, internalized 25HC accumulates in the late endosomes and blocks cholesterol export, thereby restricting SARS-CoV-2 spike protein catalyzed membrane fusion. Our results highlight a unique antiviral mechanism of 25HC and provide the molecular basis for its possible therapeutic development.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- 25-hydroxycholesterol promotes brain endothelial dysfunction by remodelling cholesterol metabolism
Víctor S. Tapia, Sarah E. Withers, … Paul R. Kasher·Disease Models & MechanismsPeer-reviewed·May 23, 2025
- Evaluation of endogenous and therapeutic 25-hydroxycholesterols in murine models of pulmonary SARS-CoV-2 infection
M. B. Fessler, J. Madenspacher, … K. D. Mayer-Barber·bioRxiv·Sep 12, 2022
- Membrane Fusion Inhibition, Immune Modulation, and Cholesterol Synthesis Dysregulation During Dengue Virus Inhibition by 25-Hydroxycholesterol
Debayani Chakraborty, Achinta Sannigrahi, … Rahul Roy·bioRxiv·May 31, 2025
- Cholesterol Remodeling by CH25h Rewires IFITM3 Trafficking and Secretion Without Enhancing Antiviral Restriction
Yuxin Song, Julien Burlaud‐Gaillard, … Andrea Cimarelli·bioRxiv·Dec 11, 2025
- SARS-CoV-2 Requires Cholesterol for Viral Entry and Pathological Syncytia Formation
D. W. Sanders, C. C. Jumper, … C. P. Brangwynne·bioRxiv·Dec 14, 2020
- Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
Z. Yuan, M. A. Pavel, … S. Hansen·bioRxiv·Aug 13, 2020